Title : RET activation inhibits doxorubicin-induced apoptosis in SK-N-MC cells.

Pub. Date : 2008 Jul-Aug

PMID : 18751369






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RET activation inhibits doxorubicin-induced apoptosis in SK-N-MC cells. sk-n-mc ret proto-oncogene Homo sapiens
2 MATERIALS AND METHODS: Each RET isoform was separately expressed in SK-N-MC cells (neural crest-derived tumor) and the impact of RET activation on doxorubicin-induced apoptosis was examined. sk-n-mc ret proto-oncogene Homo sapiens
3 RESULTS: The activation of RET9 and RET51 in the SK-N-MC cells significantly reduced the doxorubicin-induced apoptosis by 50%, compared to untreated cells. sk-n-mc ret proto-oncogene Homo sapiens
4 CONCLUSION: In SK-N-MC cells, downstream activation of MAP kinase, by both RET9 and RET51, appears to mediate the majority of RET-dependent resistance to chemotherapeutically induced apoptosis. sk-n-mc ret proto-oncogene Homo sapiens
5 CONCLUSION: In SK-N-MC cells, downstream activation of MAP kinase, by both RET9 and RET51, appears to mediate the majority of RET-dependent resistance to chemotherapeutically induced apoptosis. sk-n-mc ret proto-oncogene Homo sapiens